Observe Medical ASA announced that the Group, via its UK distributor C&P Medical, has been awarded onto the Scottish NHS Urology Framework with UnometerTM 500. This is a 3 year contract until end of March 2027, effective from April 2024. NHSScotland consists of 14 geographically based local NHS boards with over 180 individual NHS hospitals containing more than 13,000 available staffed beds for acute specialities.NHS Scotland has historically ordered more than 150,000 units annually of UnometerTM of a total UK market of approximately 800,000 units annually.

Anticipating a continuation of this strong demand, this new Framework agreement holds the potential to generate annual revenues exceeding NOK 13 million. Building on the recent announcement made on September 11, 2023, regarding Observe Medical's acquisition of trademarks and other intellectual property rights for the Unometer? and Abdo-Pressure?

products, the company is thrilled to unveil this major agreement with NHS Scotland for distribution of Unometer? 500 product. This marks a substantial milestone in the ongoing development of the Unometer?

business, which has traditionally generated annual revenues exceeding NOK 200 million.